Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain

Details for Australian Patent Application No. 2005212517 (hide)

Owner Amgen Inc.

Inventors Wang, Hui-Ling; Gore, Vijay Keshav; Katon, Jodie; Norman, Mark H.; Doherty, Elizabeth M.; Balan, Chenera; Falsey, James R.

Agent Shelston IP

Pub. Number AU-B-2005212517

PCT Pub. Number WO2005/077944

Priority 60/543,896 11.02.04 US

Filing date 11 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 21 May 2009

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077944 Priority application(s): WO2005/077944

21 May 2009 Application Accepted

  Published as AU-B-2005212517

17 September 2009 Standard Patent Sealed

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212522-Plant nutrient reduction system

2005212510-Chemokine receptor antagonists